Q-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes
21.2
SEK-1.4
percentQ-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
Nasdaq Stockholm(QLINEA): Quotes are delayed 15 minutes
21.2
SEK-1.4
percentFuture-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
Press releases
Q-linea announces FDA clearance of expanded ASTar blood testing menu
Q-linea announces shipment of two ASTar® instruments to Saudi Arabia
The nomination committee’s proposals to Q-linea’s annual general meeting 2026
The nomination committee of Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) has submitted its proposals to Q-linea´s annual general meeting…
Read more >
Keep up to date – subscribe
Christer Samuelsson
Investor Relations
Phone: +46 18 444 36 10
Mobile: +46 70 600 15 20
.
.
.